Beyond the Genome: The Epitranscriptomic Revolution and the Quest for Precision Medicine
In the high-stakes world of precision medicine, the biological map is constantly being redrawn. For decades, the focus has remained...
In the high-stakes world of precision medicine, the biological map is constantly being redrawn. For decades, the focus has remained...
Broadcast Date: Thursday, October 15, 2026 Featured Expert: Joshua Michael Hare, MD, Founding Director, Interdisciplinary Stem Cell Institute, University of...
The landscape of genetic engineering is undergoing a tectonic shift. For over a decade, the CRISPR-Cas9 system has dominated the...
The pharmaceutical landscape is undergoing a profound transformation. Once relegated to the periphery of medical research and hindered by decades...
In a significant move toward the industrialization of cell-based medicine, Cellares and Sonoma Biotherapeutics have announced a strategic partnership aimed...
The landscape of modern biotechnology is currently defined by two diverging paths to value creation: the high-velocity, algorithmic precision of...
In a breakthrough that could fundamentally alter the trajectory of neurodegenerative disease management, a landmark Phase I/II clinical study has...
The landscape of genome editing has been defined by the rapid ascent of CRISPR-Cas9, a tool that transformed molecular biology...
As the global scientific community gathers in Montreal for the International Society for Stem Cell Research (ISSCR) 2026 meeting from...
The bioprocessing industry stands at a critical juncture. As cell and gene therapies move from niche academic experiments to life-saving...
In a landmark achievement for regenerative medicine and ophthalmology, a team of biomedical engineers at Duke University has successfully generated...
NEW YORK CITY — In the heart of midtown Manhattan, the global scientific community converged last week to honor two...